Chandrasekaran Ramakrishnan, Cognizant Technology Solutions (CTSH)’s insider Sold 25,000 Shares; Sphera Funds Management LTD Has Raised Prothena Plc (PRTA) Position

As reported in a legally required report filed with the Washington-based SEC on 24/01/2018, Chandrasekaran Ramakrishnan, Ex. Vice Chairman – Cog. India of Cognizant Technology Solutions Corp and a well informed person, unloaded 25,000 shares of the corporation for close to $1,950,000 USD based on an average share price of $78.0. He also sold 75,000 shares that are worth about $5,711,000 USD in the last 30 days. Right now, he possess a total of 196,300 shares or 0.03% of Cognizant Technology Solutions Corp’s total market cap. It is an important deal and hence it will most likely not stay unseen.

Sphera Funds Management Ltd increased Prothena Corp Plc (PRTA) stake by 50% reported in 2017Q3 SEC filing. Sphera Funds Management Ltd acquired 20,000 shares as Prothena Corp Plc (PRTA)’s stock rose 4.04%. The Sphera Funds Management Ltd holds 60,000 shares with $3.89 million value, up from 40,000 last quarter. Prothena Corp Plc now has $1.68B valuation. The stock decreased 1.64% or $0.73 during the last trading session, reaching $43.72. About 303,467 shares traded. Prothena Corporation plc (NASDAQ:PRTA) has risen 41.05% since January 25, 2017 and is uptrending. It has outperformed by 24.35% the S&P500.

Among 14 analysts covering Prothena Corp (NASDAQ:PRTA), 13 have Buy rating, 0 Sell and 1 Hold. Therefore 93% are positive. Prothena Corp had 29 analyst reports since July 22, 2015 according to SRatingsIntel. Cantor Fitzgerald maintained Prothena Corporation plc (NASDAQ:PRTA) rating on Wednesday, November 8. Cantor Fitzgerald has “Buy” rating and $80.0 target. On Tuesday, August 4 the stock rating was maintained by Wedbush with “Outperform”. The rating was maintained by RBC Capital Markets with “Buy” on Thursday, November 2. On Friday, September 29 the stock rating was maintained by BTIG Research with “Buy”. On Thursday, November 19 the stock rating was maintained by RBC Capital Markets with “Outperform”. The firm has “Outperform” rating by Credit Suisse given on Thursday, January 21. Deutsche Bank maintained Prothena Corporation plc (NASDAQ:PRTA) rating on Monday, October 23. Deutsche Bank has “Buy” rating and $73.0 target. The rating was initiated by Barclays Capital with “Overweight” on Friday, May 13. The stock of Prothena Corporation plc (NASDAQ:PRTA) has “Outperform” rating given on Friday, February 19 by Wedbush. The stock of Prothena Corporation plc (NASDAQ:PRTA) has “Buy” rating given on Thursday, July 6 by Oppenheimer.

Investors sentiment decreased to 1.65 in 2017 Q3. Its down 0.06, from 1.71 in 2017Q2. It turned negative, as 12 investors sold PRTA shares while 28 reduced holdings. 20 funds opened positions while 46 raised stakes. 31.24 million shares or 2.01% more from 30.62 million shares in 2017Q2 were reported. Omers Administration Corp stated it has 5,100 shares. Bb Biotech Ag has invested 0.63% of its portfolio in Prothena Corporation plc (NASDAQ:PRTA). 500 were reported by Winslow Evans Crocker. Blackrock accumulated 3.01 million shares. Ameritas Prtnrs has invested 0.01% in Prothena Corporation plc (NASDAQ:PRTA). Amer Century Inc reported 0% stake. Pointstate Cap LP has invested 0.19% in Prothena Corporation plc (NASDAQ:PRTA). State Of Wisconsin Invest Board reported 27,000 shares or 0.01% of all its holdings. Focused Wealth holds 0.2% or 9,250 shares in its portfolio. Ubs Asset Mngmt Americas stated it has 48 shares. Axa holds 0.04% of its portfolio in Prothena Corporation plc (NASDAQ:PRTA) for 144,465 shares. Wellington Management Gru Llp reported 0.05% stake. Price T Rowe Associates Incorporated Md holds 5.45 million shares or 0.06% of its portfolio. Proshare Advisors Ltd Liability Com accumulated 24,197 shares. Citigroup owns 17,616 shares.

Since September 25, 2017, it had 0 buys, and 7 insider sales for $2.97 million activity. Shares for $224,583 were sold by Selkoe Dennis J.. $1.21M worth of Prothena Corporation plc (NASDAQ:PRTA) was sold by Nickerson Tara on Wednesday, September 27. On Thursday, September 28 the insider HENNEY CHRISTOPHER S sold $63,000. Shares for $105,000 were sold by Walker Karin L. The insider Zago Wagner M. sold 900 shares worth $63,000. Kinney Gene G. sold 2,800 shares worth $196,000.

Sphera Funds Management Ltd decreased Dova Pharmaceuticals Inc stake by 16,716 shares to 78,284 valued at $1.90M in 2017Q3. It also reduced Therapeuticsmd Inc (NYSEMKT:TXMD) stake by 200,000 shares and now owns 380,000 shares. Ituran Location And Control (NASDAQ:ITRN) was reduced too.

Cognizant Technology Solutions Corporation provides information technology , activities and technology consulting, infrastructure, and business process services worldwide. The company has market cap of $46.26 billion. The firm operates through four divisions: Financial Services, Healthcare, Manufacturing/Retail/Logistics, and Other. It has a 24.31 P/E ratio. The Company’s consulting and technology services include strategy consulting, business and activities consulting, technology strategy and change management, and program management consulting services; application design and development; systems integration; and application testing, consulting, and engineering services, as well as enterprise information management services.

Analysts await Cognizant Technology Solutions Corporation (NASDAQ:CTSH) to report earnings on February, 14. They expect $0.88 earnings per share, up 15.79% or $0.12 from last year’s $0.76 per share. CTSH’s profit will be $518.89 million for 22.29 P/E if the $0.88 EPS becomes a reality. After $0.93 actual earnings per share reported by Cognizant Technology Solutions Corporation for the previous quarter, Wall Street now forecasts -5.38% negative EPS growth.

The stock increased 0.24% or $0.19 during the last trading session, reaching $78.45. About 3.66 million shares traded. Cognizant Technology Solutions Corporation (NASDAQ:CTSH) has risen 5.50% since January 25, 2017 and is uptrending. It has underperformed by 11.20% the S&P500.

Among 30 analysts covering Cognizant Technology Solutions Corp. (NASDAQ:CTSH), 24 have Buy rating, 1 Sell and 5 Hold. Therefore 80% are positive. Cognizant Technology Solutions Corp. has $93 highest and $48 lowest target. $79.70’s average target is 1.59% above currents $78.45 stock price. Cognizant Technology Solutions Corp. had 76 analyst reports since August 6, 2015 according to SRatingsIntel. Citigroup maintained it with “Neutral” rating and $52 target in Monday, October 3 report. The rating was upgraded by Citigroup on Thursday, January 18 to “Buy”. Loop Capital initiated the stock with “Hold” rating in Tuesday, January 10 report. The stock has “Buy” rating by Needham on Thursday, August 6. Credit Suisse maintained it with “Buy” rating and $89.0 target in Thursday, November 2 report. The rating was downgraded by HSBC on Thursday, June 8 to “Hold”. The stock of Cognizant Technology Solutions Corporation (NASDAQ:CTSH) earned “Outperform” rating by RBC Capital Markets on Tuesday, February 9. On Friday, September 30 the stock rating was downgraded by Argus Research to “Hold”. Robert W. Baird maintained Cognizant Technology Solutions Corporation (NASDAQ:CTSH) on Thursday, October 12 with “Buy” rating. The stock of Cognizant Technology Solutions Corporation (NASDAQ:CTSH) has “Outperform” rating given on Thursday, August 6 by BMO Capital Markets.

Investors sentiment increased to 1.03 in Q3 2017. Its up 0.27, from 0.76 in 2017Q2. It is positive, as 37 investors sold Cognizant Technology Solutions Corporation shares while 296 reduced holdings. 99 funds opened positions while 244 raised stakes. 487.81 million shares or 3.03% less from 503.05 million shares in 2017Q2 were reported. Whittier Of Nevada Inc accumulated 7,149 shares or 0.05% of the stock. Highvista Strategies Ltd holds 0.13% or 7,700 shares in its portfolio. Pennsylvania-based Haverford Tru has invested 0.01% in Cognizant Technology Solutions Corporation (NASDAQ:CTSH). Signaturefd Limited Liability holds 0.06% or 6,642 shares. Bluemountain Capital Limited Liability Com accumulated 30,209 shares or 0.04% of the stock. Fulton Comml Bank Na owns 23,833 shares. Nationwide Fund Advisors reported 0.1% of its portfolio in Cognizant Technology Solutions Corporation (NASDAQ:CTSH). National Bank Of Nova Scotia Trust Company owns 1,670 shares or 0.01% of their US portfolio. Tru Company Of Oklahoma has 1.11% invested in Cognizant Technology Solutions Corporation (NASDAQ:CTSH). Wetherby Asset Mgmt Inc owns 10,181 shares. Cetera Llc holds 0.02% or 5,628 shares. Bender Robert & Associates holds 88,087 shares or 3.67% of its portfolio. Veritas Management Ltd Liability Partnership holds 7.36% or 750,952 shares in its portfolio. Dean Assocs Ltd Liability Corporation invested in 0.73% or 66,640 shares. Adirondack Tru Communication stated it has 200 shares.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: